Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)

por Muller, PCE Hissink, Brederije, I, Brinkman DMC, DMC, Allaart, CF, van Suijlekom-Smit, LWA, van Rossum, MAJ, ten Cate, R
Publicado 2011

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis

por Anink, J, Otten, MH, Van Suijlekom-Smit, LA, Van Rossum, MA, Dolman, KM, Hoppenreijs, EP, Ten Cate, R, Vogl, T, Foell, D, Roth, J, Holzinger, D
Publicado 2013

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl

por Prince, FHM, Ferket, IS, Kamphuis, SSM, Armbrust, W, Ten Cate, R, Hoppenreijs, EPAH, Koopman-Keemink, Y, van Rossum, MAJ, van Santen-Hoeufft, M, Twilt, M, van Suijlekom-Smit, LWA
Publicado 2008

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis

por Albers, HM, Kurreeman, FAS, Houwing-Duistermaat, JJ, Brinkman, DMC, Kamphuis, SSM, Girschick, HJ, Wouters, C, van Rossum, MAJ, Verduyn, W, Toes, REM, Huizinga, TWJ, Schilham, MW, ten Cate, R
Publicado 2008

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis

por Reinards, TH, Albers, H, Brinkman, D, Kamphuis, S, Van Rossum, M, Hoppenreijs, E, Girschick, H, Wouters, C, Saurenmann, R, Toes, R, Huizinga, T, Houwing-Duistermaat, J, Schilham, M, Ten Cate, R
Publicado 2013

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

por Albers, HM, Wessels, JAM, Straaten, RJH van der, Brinkman, DMC, Suijlekom-Smit, LWA, Kamphuis, SSM, Girschick, HJ, Wouters, C, Schilham, MW, le Cessie, S, Huizinga, TWJ, ten Cate, R, Guchelaar, HJ
Publicado 2008

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study

por Hissink Muller, PC, Westedt, PM, Budding, AE, Allaart, CF, Brinkman, DM, Kuijpers, TW, Van den Berg, JM, Van Suijlekom-Smit, LW, Van Rossum, MA, De Meij, TG, Ten Cate, R
Publicado 2013

Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis

por Reinards, THCM, Albers, HM, Brinkman, DMC, Kamphuis, SSM, van Rossum, MAJ, Hoppenreijs, EPAH, Girschick, HJ, Wouters, C, Saurenmann, RK, Houwing-Duistermaat, JJ, Toes, REM, Huizinga, TWJ, ten Cate, R, Schilham, MW
Publicado 2011

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis

por Reinards, THCM, Albers, HM, Brinkman, DMC, Kamphuis, SSM, van Rossum, MAJ, Hoppenreijs, EPAH, Girschick, HJ, Wouters, C, Saurenmann, RK, Houwing-Duistermaat, JJ, Toes, REM, Huizinga, TWJ, ten Cate, R, Schilham, MW
Publicado 2011

Does incorporation of aids/devices and help, make a difference in the childhood health assessment questionnaire disability index? Analysis from the printo juvenile idiopathic arthr...

por Saad-Magalhães, C, Pistorio, A, Ravelli, A, Brik, R, Mihaylova, D, Ten Cate, R, Andersson-Gare, B, Ferriani, V, Minden, K, Hashkes, P, Rygge, M, Sauvain, MJ, Venning, H, Martini, A
Publicado 2008

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

por Prince, FHM, Twilt, M, Simon, SCM, van Rossum, MAJ, Armbrust, W, Hoppenreijs, EPAH, Kamphuis, SSM, van Santen-Hoeufft, M, Koopman-Keemink, Y, Wulffraat, N, ten Cate, R, van Suijlekom-Smit, LWA
Publicado 2008

Etanercept in juvenile idiopathic arthritis: Who will benefit?

por Otten, MH, Prince, FHM, Armbrust, W, ten Cate, R, Hoppenreijs, EPAH, Twilt, M, Koopman-Keemink, Y, Gorter, SL, Dolman, KM, Swart, JF, van den Berg, JM, Wulffraat, NM, van Rossum, MAJ, van Suijlekom-Smit, LWA
Publicado 2011

Resetting the Adaptive Immune System After Autologous Stem Cell Transplantation: Lessons from Responses to Vaccines

por Brinkman, D. M. C., Jol-van der Zijde, C. M., ten Dam, M. M., te Boekhorst, P. A. W., ten Cate, R., Wulffraat, N. M., Hintzen, R. Q., Vossen, J. M., van Tol, M. J. D.
Publicado 2007

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register

por Otten, MH, Anink, J, Prince, FH, Twilt, M, Vastert, SJ, Ten Cate, R, Hoppenreijs, EP, Armbrust, W, Gorter, SL, Van Pelt, PA, Kamphuis, S, Dolman, KM, Swart, JF, Van den Berg, JM, Koopman-Keemink, Y, Van Rossum, MA, Wulffraat, NM, Van Suijlekom-Smit, LA
Publicado 2013

A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study

por Hissink Muller, P. C. E., Brinkman, D. M. C., Schonenberg, D., Koopman-Keemink, Y., Brederije, I. C. J., Bekkering, W. P., Kuijpers, T. W., van Rossum, M. A. J., van Suijlekom-Smit, L. W. A., van den Berg, J. M., Allaart, C. F., ten Cate, R.
Publicado 2017

No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis

por Hissink Muller, P. C. E., van Braak, W. G., Schreurs, D., Nusman, C. M., Bergstra, S. A., Hemke, R., Schonenberg-Meinema, D., van den Berg, J. M., Kuijpers, T. W., Koopman-Keemink, Y., van Rossum, M. A. J., van Suijlekom-Smit, L. W. A., Brinkman, D. M. C., Allaart, C. F., ten Cate, R., Maas, M.
Publicado 2019